Advertisement

Innovation

Hospital and health system venture capital arms help provide financial investment and resources to startups. If successful, these companies have the potential to generate additional revenue for the health system.

Syndax, a biopharmaceutical company focusing on cancer therapies, has announced the pricing of a $150 million public offering of common stock.

Advertisement

Imaging company Endoluxe has entered into a know-how agreement with Rochester, Minn.- based Mayo Clinic to research the uses of artificial intelligence and machine learning in the treatment of bladder cancer.

Advertisement